Good to have you back!
If you've signed in to StudyBlue with Facebook in the past, please do that again.
Medicinal Chemistry 745
Medicinal Chemistry 745
† The material on this site is created by StudyBlue users. StudyBlue is not affiliated with, sponsored by or endorsed by the academic institution or instructor.
Get started today
1Ashok Philip, Ph.D. Assistant Professor of Pharmaceutical Sciences 731-661-5704 (office) firstname.lastname@example.org Antineoplastic Agents-3 1. Wilsons and Gisvold?s Textbook of Organic Medicinal and Pharmaceutical Chemistry, 12th Edition, Copyright ©2011 Lippincott Williams & Wilkins 2. FOYE?s Principles of Medicinal Chemistry, 6th Edition, Copyright ©2008 Lippincott Williams & Wilkins 3. Drug Labels accessed from: http://dailymed.nlm.nih.gov/dailymed/about.cfm 4. Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy (2nd edition) Golan et. al; Lippincott Williams & Wilkins, 2008 5. Goodman and Gilman?s The Pharmacological Basis of Therapeutics, 12th Ed. Laurence L Brunton, John S. Lazo, and Keith L Parker, Eds. New York: McGraw-Hill, 2006. Reference Books: 1 Goal: To provide students with the medicinal chemistry perspective of Antineoplastic agents LECTURE 20 Objectives: Students should be able ? To outline various therapeutic classes of agents for Cancer Chemotherapy ? To understand the Mechanisms by which antineoplastic agents act ? To understand the mechanisms responsible for adverse effects observed with antineoplastic agents ? To understand the chemical composition and SAR of antineoplastic agents 2 2The Cell Cycle 3 Summary of mechanisms and sites of action of some agents 4 31. Nitrogen Mustards 2. Nitrosoureas 3. Procarbazine and Triazenes 4. Miscellaneous alkylating agents 5. Organoplatinum complexes 5 I. Alkylating Agents (DNA Cross-Linking Agents) I. Alkylating Agents 2. Nitrosoureas Carmustine (BiCNU®) Lomustine (CeeNU®) Streptozocin (Zanosar®) Bifunctional in nature & cause interstrand DNA Cross-linking 6 4Mechanism of action Decompose readily in aqueous environment of cell to Cytotoxic Electrophiles 2. Nitrosoureas - 2 decomposition Pathways A and B Pathway A Capable of alkylating DNA 7 Mechanism of action A second decomposition mechanism produces electrophilic 2-chloroethylcarbocation capable of DNA alkylation at N7 and O6 of Guanine 2. Nitrosoureas Pathway B Also an isocyanate produced that can carbamylate amino acid residues like Lys 8 5Mechanism of action2. Nitrosoureas Pathway B 9 Carmustine and Lomustine - Both highly lipophilic compounds - Marketed for use in Brain tumors and Hodgkin's disease High lipophilicity of Carmustine prevents a totally aqueous IV formulation Hence administered in 10% ethanol 2. Nitrosoureas Carmustine (BiCNU®) Lomustine (CeeNU®) - Therefore, readily cross BBB 10 6Carmustine and Lomustine 2. Nitrosoureas Stability: - Carmustine degrades within 15 minutes of IV administration - Lomustine is stable enough for oral use and marketed in capsule form - Carmustine decomposes if exposed to temperatures around 90°F - Pure Carmustine is a low-melting solid, - Decomposed Carmustine is an oil - Vials of Carmustine that appear oily should be discarded 11 2. Nitrosoureas Indicated for metastatic islet cell carcinoma of pancreas Reason: Glucopyranose moiety confers both islet cell specificity & high water solubility Much less reactive as a DNA alkylating agent than other nitrosoureas ? Due to lack of 2-chloroethyl substituent BBW: Dose-related renal toxicity can be severe or fatal Streptozocin (Zanosar®) 12 73. Procarbazine and Triazenes ? DNA Methylators Procarbazine (Matulane®) Dacarbazine (DTIC) Temozolamide (Temodar®) A methylhydrazine derivative Triazenes 13 3. Procarbazine and Triazenes ? DNA Methylators Mechanism of action (Cell Cycle Non-Specific Action) - All exert antineoplastic effect through O6- methylation of Guanine nucleotides Result: O6-methylguanine pairs preferentially with Thymine These ?mispairs? prompt point mutations during subsequent DNA replication cycles & trigger cell destruction Consequence: Patients able to repair this damage by transferring offending CH3 group to a Cys residue on alkyltransferase enzyme Exhibit resistance to these agents 14 83. Procarbazine Mechanism of action - A Methyl radical generator used for Hodgkin's disease & malignant brain tumors - Part of a multidrug regimen CYP1A CYP2B Methyl radical 15 3. Triazenes Mechanism of action Dacarbazine (DTIC) Temozolamide (Temodar®) CYP1A1 CYP1A2 Nonenzymatic 16 H2O + Diazomethane Diazomethane+ 94. Miscellaneous DNA Alkylating Agents Altretamine: Believed to damage tumor cells via production of weakly alkylating Formaldehyde species Mechanism of action Formaldehyde - Product of CYP450-mediated N-demethylation Altretamine (Hexalen®) PMM (Pentamethyl melamine 17 Busulfan : One or both of methylsulfonate ester moieties displaced by nucleophilic N7 of Guanine - Leads to either monoalkylated or cross-linked DNA Mechanism of action Busulfan (Myleran®) - Is an alkylsulfonate 4. Miscellaneous DNA Alkylating Agents 18 10 Busulfan - Mechanism of action 19 5. Organoplatinum Complexes Contain an electron-deficient metal atom ? Platinum (Pt) 20 11 Mechanism of action Electron-deficient (Pt) metal atom acts as a magnet for electron-rich DNA nucleophiles Like nitrogen mustards also are bifunctional & can accept electrons from two DNA nucleophiles 5. Organoplatinum Complexes Intrastrand cross-links more commonly occur between adjacent guanine residues 21 5. Organoplatinum Complexes Mechanism of action: Cisplatin Chloride-poor environment of tumor cell facilitates the generation of active, cytotoxic hydrated forms 22 12 5. Organoplatinum Complexes Cisplatin - Highly Nephrotoxic (patients should be hydrated with saline/Mannitol) Given IV for treatment of metastatic testicular and ovarian cancer and advanced bladder cancer - Myelosuppression and Ototoxicity (irreversible hearing loss) Cisplatin & other Organoplatinum anticancer agents react with Aluminum Cannot be administered through aluminum-containing needles - Is photosensitive& packaged in amber bottles & must be protected from light 23 5. Organoplatinum Complexes Oxaliplatin (oxalate anion) Intrastrand Pt-DNA crosslinks formed - Decomposes in alkaline media, should not be co-administered with drugs that increase pH of IV solution 24 13 - Conformation of Oxaliplatin-DNA adduct is LESS susceptible to MMR proteins - MMR proteins INITIATE APOPTOSIS 5. Organoplatinum Complexes - Resistance - Conformation of Cisplatin-DNA adduct HIGHLY susceptible to MisMatchRepair (MMR) proteins - Cisplatin-DNA adduct bends DNA by 60-80° & presents a wide minor groove - Oxaliplatin-DNA adduct bends DNA by 31° only & produces only narrow minor groove - MMR-deficient Cells exhibit RESISTANCE to Cisplatin - MMR-deficient Cells still SUSCEPTIBLE to Oxaliplatin 25 Ashok Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel NOP (nociceptin/orphanin FQ peptide) Receptor Ligands.
Want to see the other 13 page(s) in L20_Antineoplastic_Agents_...pdf?
JOIN TODAY FOR FREE!
Words From the Students
"The semester I found StudyBlue, I went from a 2.8 to a 3.8, and graduated with honors!"
Colorado School of Mines
Get started today
Show & Tell
StudyBlue is not sponsored or endorsed by any college, university, or instructor.
© 2014 StudyBlue Inc. All rights reserved.